Original Research

Frequency of Contrast-Induced Nephropathy in Type 2 Diabetes Mellitus Patients Underwent Percutaneous Coronary Intervention for Acute Coronary Syndrome

Waqar Ahmad
Mayo Hospital Lahore
Anas Sajjad
Mayo Hospital Lahore
Farwa Abbas
Mayo Hospital Lahore
Amna Riaz
Mayo Hospital Lahore
Rae Hasnain Shehzad
Mayo Hospital Lahore
Iqra Waheed
Mayo Hospital Lahore

✉ Correspondence: Waqar Ahmad Email: doc_waqar10@yahoo.com

DOI https://doi.org/10.70302/jpsim.v4i2.2326
Volume: 4, Issue 2 Pages: 125–129 Published: 02 Jun 2023
Received: 03 Feb 2023 Accepted: 06 Mar 2023 Published Online: 02 Jun 2023

Abstract

Objective

The purpose of this study was to determine the incidence of contrast-induced nephropathy in patients with type 2 diabetes mellitus who had percutaneous coronary intervention for acute coronary syndrome.

Methods

This descriptive study was undertaken in Department of Cardiology, Mayo Hospital, Lahore during July 2018 to January 2019. Total 165 patents fulfilling selection criteria were enrolled in the study. Then all patients underwent PCI. After that, patients were sent to cardiology wards and monitored for the next two days. Serum creatinine levels were measured after 48 hours of blood collection. If creatinine>25% from baseline, then CIN was labelled.

Results

The mean age of patients was 55.75±6.05 years. There were 125(75.8%) males and 40(24.2%) females. The mean duration of diabetes mellitus was 7.97±0.98 years. The mean duration of ACS was 10.84±5.95hours. There were 57(34.54%) patients who were diagnosed with CIN.

Conclusion

The frequency of CIN in type 2 diabetes mellitus patients underwent PCI for ACS was 34.54%.

Keywords
Contrast-induced nephropathy type 2 diabetes mellitus percutaneous coronary intervention

How to Cite This Article

Ahmad W, Sajjad A, Abbas F, Riaz A, Shehzad RH, Waheed I. Frequency of Contrast-Induced Nephropathy in Type 2 Diabetes Mellitus Patients Underwent Percutaneous Coronary Intervention for Acute Coronary Syndrome. J Pak Soc Intern Med. 2023;4(2):125–129. doi:10.70302/jpsim.v4i2.2326

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced nephropathy. Heart views: Official J Gulf Heart Assoc. 2013;14(3):106.
  2. Barbieri L, Verdoia M, Schaffer A, Cassetti E, Di Giovine G, Marino P, et al. Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. Diab Res Clin Prac. 2014;106(3):458-64.
  3. Heyman SN, Rosenberger C, Rosen S, Khamaisi M. Why is diabetes mellitus a risk factor for contrast-induced nephropathy? BioMed Res Int. 2013; https://doi.org/10.1155/2013/123589. doi:10.1155/2013/123589
  4. Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, et al. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014;63(1):62-70.
  5. Deng J, Wu G, Yang C, Li Y, Jing Q, Han Y. Rosuvastatin attenuates contrast-induced nephropathy through modulation of nitric oxide, inflammatory responses, oxidative stress and apoptosis in diabetic male rats. J Translational Med. 2015;13(1):53.
  6. Tsai M-L, Mao C-T, Chen D-Y, Hsieh I-C, Wen M-S, Chen T-H. Short-and long-term major cardiovascular adverse events in carotid artery interventions: a nationwide population-based cohort study in Taiwan. PloS one. 2015;10(3):e0121016.
  7. Jin B, Wu B, Zhang J, Luo X, Shi H. Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial. Brazilian J Med Biolog Res. 2015;48(9):839-42.
  8. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol. 2004;183(6):1673-89.
  9. Zhang M-M, Lv Q-Z, Li X-Y. Drug effects and clinical investigations for contrast-induced nephropathy after coronary angiography or percutaneous coronary intervention in patients with diabetes. Am J Therapeut. 2017;24(4):e423-e30.
  10. Sany D, Refaat H, Elshahawy Y, Mohab A, Ezzat H. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients. Renal Failure. 2014;36(2):191-7.
  11. Shamkhalova M, Zaĭtseva N, Kurumova K, Shestakova M, Deev A, Matskeplishvili S, et al. Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches. Terapevticheskii Arkhiv. 2009;81(8):36-42.
  12. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-9.
  13. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89(5):615-20.
  14. Kumar S, Nair RK, Aggarwal N, Abbot A, Muthukrishnan J, Kumar KH. Risk factors for contrast-induced nephropathy after coronary angiography. Saudi J Kidney Dis Transplant. 2017;28(2):318.
  15. Toprak O, Cirit M. Risk Factors for Contrast-Induced Nephropathy. Kidney Blood Pressure Res. 2006;29(2):84-93.
  16. Roy P, Raya V, Okabe T, Slottow TLP, Steinberg DH, Smith K, et al. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101(11):1544-9.
  17. Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004;93(12):1515-9.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2023 Journal of Pakistan Society of Internal Medicine.
📃 In This Issue View All
Review Article Statin Therapy in Non-Alcoholic Fatty Liver Disease: A Systematic Review Nawaz F, Cheema HA, Mehmood Y Review Article Thyroid Disorders in Pregnancy: Clinical Implications and Management Strategies Baig BI, Usman A Original Article Serum Ferritin as a Prognostic Marker in COVID-19 Severity: A Hospital-Based Study Rehman N, Sheikh I, Javed K Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T
👥 More by These Authors
Review Article Antibiotic Resistance Patterns in Community-Acquired Pneumonia: Emerging Trends Hussain I, Farooq Z Original Article Comparison of Ultrasound-Guided versus Landmark-Based Central Venous Catheter Insertion Zafar S, Gillani SA Original Article Cervical Cancer Screening Awareness Among Rural Women in Punjab Bibi S, Anjum R, Hassan F Original Article Outcomes of Laparoscopic Cholecystectomy in Acute Cholecystitis: A Retrospective Analysis Raza SH, Butt N, Qureshi AM
🔗 Related Articles By Keywords
Original Article Serum Ferritin as a Prognostic Marker in COVID-19 Severity: A Hospital-Based Study Rehman N, Sheikh I, Javed K Original Article Impact of Diabetes Mellitus on Post-Operative Wound Healing in General Surgery Siddiqui FA, Noor M, Akhtar W Original Article Neonatal Sepsis: Bacteriological Profile and Antibiogram in a Tertiary Care Hospital Iqbal M, Rashid T Original Article Prevalence of Hypertension Among Urban Adults in Pakistan: A Cross-Sectional Study Khan TM, Ahmed S, Malik RA